supplementhackr
Stacker 2

Stacker 2 Capsules

Serving
1 Capsule(s)
Form
capsule-unknown
UPC
358286940047
DSLD
19303
Formula hash
de2b9a32cae7
Brand context
Stacker 2
Catalog
7
products
With avoid flag
2
products
FDA recalls
0
history
CAERS
26
reports
Avoid-flaggedObjective label signals
Flagged excipients
5
1 avoid · 4 caution
FDA recalls
0
no recall history
CAERS reports
15
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

3 active ingredients
IngredientAmount% DV
Proprietary Blend
Proprietary Blend (Combination)other
198 mg—
Caffeine
herbUNII · 3G6A5W338E
200 mg—
Tri-Gugglyptoid3 Complex(TM)
Proprietary Blend (Combination)other
25 mg—
Flagged excipients

5 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

    eur-lex.europa.eu →efsa.europa.eu →ecfr.gov →
  • ◐ CAUTIONFD&C YELLOW #5
    color

    EU requires warning label 'may have an adverse effect on activity and attention in children' per Commission Regulation 1333/2008 Annex III (following Southampton study 2007). FDA requires specific label declaration (21 CFR 74.705).

    eur-lex.europa.eu →ecfr.gov →
  • ◐ CAUTIONFD&C BLUE #1
    color

    EU requires 'attention in children' warning per Commission Regulation 1333/2008 Annex III. Limited to specific food categories; capsule-shell use permitted with restrictions.

    eur-lex.europa.eu →
  • ◐ CAUTIONFD&C RED #3
    color

    FDA revoked food/ingested-drug color additive approval for FD&C Red 3 in January 2025 (Docket FDA-2022-C-2886). Manufacturers have until January 2027 (foods) / January 2028 (ingested drugs) to reformulate.

    fda.gov →federalregister.gov →
  • ◐ CAUTIONFD&C YELLOW #6
    color

    EU requires 'attention in children' warning per Reg 1333/2008 Annex III (Southampton study 2007). Banned in Norway + Finland; allowed in US under 21 CFR 74.706 with declaration.

    eur-lex.europa.eu →
FDA CAERS · adverse event context
15
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Dextrose · Gelatin · Stearic Acid · Magnesium Stearate